About Tomocube
Tomocube is a company based in Daejeon (South Korea) founded in 2015. Tomocube has raised $2 million across 1 funding round from investors including SBVA. The company has 65 employees as of December 31, 2024. Tomocube operates in a competitive market with competitors including Oxford Instruments, Olympus, M Squared, Park Systems and Phase Focus, among others.
- Headquarter Daejeon, South Korea
- Employees 65 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tomocube, Inc.
-
Annual Revenue
$7.83 M (USD)90.39as on Dec 31, 2025
-
Net Profit
-$3.33 M (USD)42.06as on Dec 31, 2025
-
EBITDA
-$5.12 M (USD)-34.54as on Dec 31, 2024
-
Total Equity Funding
$2 M (USD)
in 1 rounds
-
Latest Funding Round
$2 M (USD), Series A
Apr 04, 2016
- Investors
-
Employee Count
65
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tomocube
Tomocube is a publicly listed company on the KRX with ticker symbol 475960 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Tomocube
Unlock access to complete
Funding Insights of Tomocube
Tomocube has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Series A round of $2 million completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tomocube
Tomocube has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SBVA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital arm of SoftBank Group
|
Locked | Locked | Locked |
Investor details for Tomocube
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tomocube
Investment portfolio details for Tomocube
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tomocube
Detailed financials for Tomocube
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tomocube Comparisons
Peer comparison for Tomocube
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tomocube
Tomocube operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Olympus, M Squared, Park Systems and Phase Focus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology tools and systems for molecular scale are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of imaging and surgical products
|
|
| Locked | Locked | Locked |
Light-sheet microscopy systems are developed for biosciences verticals.
|
|
| Locked | Locked | Locked |
Scanning probe microscopes are manufactured for nanoimaging applications.
|
|
| Locked | Locked | Locked |
Provider of virtual lens that generates High definition images without high-quality lenses
|
|
| Locked | Locked | Locked |
TEM and SEM microscopy solutions for nanoscale imaging are manufactured.
|
Detailed competitors of Tomocube
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tomocube
Complete news archive for Tomocube
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tomocube
Tomocube was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Tomocube is headquartered in Daejeon, South Korea.
Tomocube is a funded company, having raised a total of $2M across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at Tomocube is 65.
Annual revenue of Tomocube is $7.83M as on Dec 31, 2025.
Tomocube was founded in 2015 in Daejeon, South Korea, and operates within the cellular microscopy sector. The Tomocell HT-1, a high-speed microscope, is produced to enable non-invasive, real-time analysis of live cells via holographic microtomography. Quantitative data on cell volume, sub-cellular organelle shapes, cytoplasmic density, surface area, and deformability are delivered at high resolutions. Applications span research and medical diagnostics.
Tomocube's top competitors include Oxford Instruments, Olympus and Park Systems.
Yes, Tomocube is publicly traded on KRX under the ticker symbol 475960.
Tomocube has 1 investor. Key investors include SBVA.
The ticker symbol of Tomocube is 475960 on KRX.